You just made this element display by using jQuery. Click the "x" in the top right corner to close this bad boy.

Featured Services

Arbour Group is a leading provider of regulatory compliance products and services for the life sciences industry.

Software Validation & Testing

Software Validation & Testing

We understand that computer systems are a key element of a company's risk management strategy.

View all Services Offered

Compliance Products

SAP Validation & Compliance

Validation is now available as a fixed-price, pre-written packaged solution.

View all Products Listing

Application Software Testing

Application Software Testing

We bring together the expertise, resources and tools required for comprehensive and cost effective testing.

View all Testing Services

Latest News

Chicago, IL - September 15, 2014 - Arbour Group To Discuss Emerging...

Placeholder image

Arbour Group, will exhibit at the 2014 RAPS conference: The Regulatory Convergence, held September 29 – October 1 2014 at the Austin Convention Center, Austin, TX. The Regulatory Convergence is sponsored by the Regulatory Affairs Professionals Society (RAPS), the largest global organization for those involved with the regulation of medical devices, pharmaceuticals, biologics and nutritional products.

Read More

Chicago, IL - September 15, 2014 - Arbour Group To Feature Comprehensive...

Placeholder image

Arbour Group, a member of the Oracle Partner Network (OPN), will exhibit at the Oracle OpenWorld conference to be held September 29 – October 3 2014 at the Moscone Center in downtown San Francisco, CA. OpenWorld is the largest customer conference held by any software development organization in North America.

Read More

Arbour Videos

The Arbour Advantage (3:28)

A combination of industry best practices in software testing...

Global Test Centers (2:22)

Essential in providing regulatory compliance economically and...

External Market Pressures (2:22)

How can Arbour Group protect your Life Sciences corporation from...

Your Part 11 Partner (6:49)

The FDA has stated its intent to increase enforcement...